Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 9/20 | 0.47 |
| ▸ | PTPN7 | P35236 | 2/20 | 0.47 |
| ▸ | DUSP3 | P51452 | 2/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | PPARG | P37231 | 3/20 | 0.44 |
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.43 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.43 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL755016 | 0.91 | EPHX2 (0.46) | EPHX2PTPN7DUSP3L3MBTL1POLB | |
| SCHEMBL756146 | 0.84 | EPHX2 (0.61) | EPHX2POLB | |
| SCHEMBL2542232 | 0.84 | EPHX2 (0.44) | EPHX2PTPN7DUSP3L3MBTL1PPARG | |
| SCHEMBL2787720 | 0.84 | EPHX2 (0.41) | EPHX2PTPN7DUSP3L3MBTL1PPARG | |
| SCHEMBL2549180 | 0.84 | L3MBTL1 (0.45) | EPHX2PTPN7DUSP3L3MBTL1POLB | |
| SCHEMBL754465 | 0.83 | AR (0.40) | EPHX2 | |
| SCHEMBL765666 | 0.82 | BDKRB1 (0.43) | EPHX2PTPN7DUSP3L3MBTL1POLB | |
| Trifluoroacetic Acid SCHEMBL2541472 | 0.82 | HDAC3 (0.43) | EPHX2PTPN7DUSP3L3MBTL1PPARG | |
| SCHEMBL2787475 | 0.82 | EPHX2 (0.42) | EPHX2PTPN7DUSP3L3MBTL1PPARG | |
| SCHEMBL3642389 | 0.82 | L3MBTL1 (0.43) | EPHX2PTPN7DUSP3L3MBTL1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2188254-A1 | NOVEL BRADYKININ B1-ANTAGONISTS | Boehringer Ingelheim International GmbH (DE) | 2010-05-26 | — | — | EP | disclosed |
| WO-2009027450-A1 | NOVEL BRADYKININ B1-ANTAGONISTS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2009-03-05 | — | — | WO | disclosed |